title: Yohimbine can be the new promising therapy for erectile dysfunction in type 2 diabetics.
authors.forename: Mohammad Shahrukh
authors.initials: MS
authors.lastname: Tanweer
authors.forename: Aelia
authors.initials: A
authors.lastname: Fatima
authors.forename: Muhammad Kazim
authors.initials: MK
authors.lastname: Rahimnajjad
mesh_terms: D000317:Adrenergic alpha-Antagonists / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003924:Diabetes Mellitus, Type 2 / Q000150:complications / Q000188:drug therapy / Q000235:genetics; D007172:Erectile Dysfunction / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D006801:Humans; D050417:Insulin-Secreting Cells; D008297:Male; D018341:Receptors, Adrenergic, alpha-2 / Q000235:genetics; D015016:Yohimbine / Q000627:therapeutic use*
chemical_list: D000317:Adrenergic alpha-Antagonists; D018341:Receptors, Adrenergic, alpha-2; D015016:Yohimbine